Cancers 2011, 3(1), 415-427; doi:10.3390/cancers3010415
Review

Cancer Stem Cells in Head and Neck Cancer

1 Department of Pathology, University of Colorado Denver, AMC 12800 E. 19th Ave., Aurora, CO 80045, USA 2 Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO 80045, USA
* Author to whom correspondence should be addressed.
Received: 2 December 2010; in revised form: 24 December 2010 / Accepted: 14 January 2011 / Published: 20 January 2011
(This article belongs to the Special Issue Cancer Stem Cells)
PDF Full-text Download PDF Full-Text [199 KB, uploaded 20 January 2011 15:05 CET]
Abstract: Head and neck cancer (HNC) is the sixth most common malignancy world-wide, however the survival rate has not improved for the past 20 years. In recent years, the cancer stem cell (CSC) hypothesis has gained ground in several malignancies and there is mounting evidence suggesting CSCs mediate tumor resistance to chemotherapy and radiation therapy. However, the CSC theory is also challenged at least in certain types of cancer. Here we review the progress of CSC studies in HNC, which suggest that HNC conforms to the CSC model. The identified CSC markers and their tumor initiation properties provide a framework for the development of novel therapeutic strategies for HNC.
Keywords: chemoresistance; radioresistance; transplantation; tumorigenicity

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Mitra, D.; Malkoski, S.P.; Wang, X.-J. Cancer Stem Cells in Head and Neck Cancer. Cancers 2011, 3, 415-427.

AMA Style

Mitra D, Malkoski SP, Wang X-J. Cancer Stem Cells in Head and Neck Cancer. Cancers. 2011; 3(1):415-427.

Chicago/Turabian Style

Mitra, Doyel; Malkoski, Stephen P.; Wang, Xiao-Jing. 2011. "Cancer Stem Cells in Head and Neck Cancer." Cancers 3, no. 1: 415-427.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert